Richard Afable - 15 Jul 2022 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (TLPH)

Role: Director
Signature: /s/ Martha Adler, Attorney-In-Fact
Issuer symbol: TLPH
Transactions as of: 15 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Jul 2022, 19:32:43 UTC
Previous filing: 17 Jun 2021
Next filing: 13 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACRX	Common Stock	Award	$0	+15,500	+70%	$0.000000	37,750	15 Jul 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACRX	Stock Option (Right to Buy)	Award	$0	+31,000		$0.000000	31,000	15 Jul 2022	Common Stock	31,000	$0.2309	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2	100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
F3	100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.